Single-dose pharmacokinetics of citalopram in patients with moderate renal insufficiency or hepatic cirrhosis compared with healthy subjects

European Journal of Clinical Pharmacology

Volumn 54, Issue 3, 1998, Pages 237-242

  Joffe, P ^a   Larsen, F S ^b   Pedersen, V ^c   Ring Larsen, H ^b   Aaes Jorgensen T ^c   Sidhu, J ^c  

^a HOLBÆK HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c H LUNDBECK A S   (Denmark)

Author keywords

Cirrhosis; Citalopram; Renal impairment

Indexed keywords

CITALOPRAM; DINORCITALOPRAM; DRUG METABOLITE; NORCITALOPRAM; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG URINE LEVEL; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY CLEARANCE; KIDNEY FAILURE; LIVER CIRRHOSIS; MALE; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; TABLET;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; BIOLOGICAL AVAILABILITY; CITALOPRAM; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; KIDNEY FAILURE; LIVER CIRRHOSIS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 0031807369     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050452     Document Type: Article

References (12)

1. Hyttel J, Arnt J, Sanchez C (1995) The pharmacology of cilalopram. Rev Contemp Pharmacother 6: 271-285
2. Øyehaug E, Østensen ET, Salvesen J (1984) High-performance liquid chromatographic determination of citalopram and four of its metabolites in plasma and urine samples from psychiatric patients. J Chromatogr A308: 199-208
3. Sindrup SH, Brøsen K, Hansen MGJ, Aaes-Jørgensen T, Overo KF, Gram LF (1993) Pharmacokinetics of citalopram in relation to the sparteine and the mephenytoin oxidation polymorphisms. Ther Drug Monit 15: 11-17
4. Baumann P, Larsen F (1995) The pharmacokinetics of citalopram. Rev Contemp Pharmacother 6: 287-295
5. Tygstrup N (1966) Determination of the hepatic elimination capacity (Lm) of galactose by single injection. Scand J Clin Lab Invest 18: 118-125
6. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R (1973) Transection of the oesophagus for bleeding oesophageal varies. Br J Surg 60: 646-649
7. Øyehaug E, Østensen ET, Salvesen B (1982) Determination of the antidepressant agent citalopram and metabolites in plasma by liquid chromatography with fluorescence detection. J Chromatogr A227: 129-135
8. Fredricson Overø K (1978) Preliminary studies of the kinetics of citalopram in man. Eur J Clin Pharmacol 14: 69-73
9. Sidhu J, Priskorn M, Poulsen M, Segonzac A, Grollier G, Larsen F (1997) Steady state pharmacokinetics of the enantiomers of citalopram and its metabolites in humans. Chirality 9: 686-692
10. Priskorn M, Larsen F, Segonzac A, Moulin M (1997) Pharmacokinetic interaction study of citalopram with cimetidine in healthy subjects. Eur J Clin Pharmacol 52: 241-242
11. Fredricson Overø K, Toft B, Christophersen L, Gylding-Sabroe JP (1985) Kinetics of citalopram in elderly patients. Psychopharmacology 86: 253-257
12. Keiding S, Andreasen PB (1979) Hepatic clearance measurements and pharmacokinetics. Pharmacology 9: 105-110